SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-104820
Filing Date
2024-09-09
Accepted
2024-09-09 17:30:03
Documents
1
Period of Report
2024-09-05

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3677
  Complete submission text file 0000950170-24-104820.txt   5438
Mailing Address ONE MAIN STREET SUITE 1350 CAMBRIDGE MA 02142
Business Address ONE MAIN STREET SUITE 1350 CAMBRIDGE MA 02142 617-410-4650
Cullinan Therapeutics, Inc. (Issuer) CIK: 0001789972 (see all company filings)

IRS No.: 813867811 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O CULLINAN MANAGEMENT, INC. ONE MAIN STREET SUITE 520 CAMBRIDGE MA 02142
Business Address
Michaelson Jennifer (Reporting) CIK: 0001838061 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39856 | Film No.: 241288130